Low-dose cytarabine and aclarubicin in combination with G-CSF (CAG) regimen for elderly patients with acute myeloid leukemia and myelodysplastic syndrome: A single institution experience

Junko Iwasaki,Daisuke Hidaka,Shojiro Takahashi,Mutsumi Takahata,Akio Shigematsu,Koichiro Minauchi,Masato Obara,Shuichi Ota,Kiyotoshi Imai,Teiichi Hirano,Masahiro Ogasawara, Naoki Kobayashi,Masahiro Imamura

Clinical Lymphoma Myeloma and Leukemia（2015）

引用 0|浏览23

暂无评分

摘要

Elderly patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are not eligible for intensive chemotherapy due to high risk of treatment-related mortality. In Asia, less intensive chemotherapy regimen consists of low-dose cytarabine and aclarubicin in combination with G-CSF (CAG) has been used for those elderly AML/MDS patients.

查看译文

关键词

Microtubule-Targeting Agents

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要